The Amadori compound is the major single modification of the extracellular matrix by the Maillard reaction in vivo. It is also a source of biologically active glycoxidation products and the formation of glucosepane, the major protein cross-link found in biological tissues so far. For this reason, introduction of deglycating enzymes as anti-aging strategy would be desirable. This article provides an update on amadoriase enzymes from fungi which, one day, will hopefully help prevent the in vivo consequences of glycation.
Introduction
Tissue aging is characterized by a progressive accumulation of insoluble material in lens and collagen-rich tissues throughout the organism. The percentage of insoluble proteins increases curvilinearly from 5% at 20 years to 95% at 90 years of age in the aging lens [1] , which concomitantly loses its ability to accommodate. The percentage of pepsin-insoluble collagen in skin increases from 65% at 18 years to more than 90% at 90 years [2] , while the collagenase solubility of tendon collagen decreases linearly with age (reviewed in [3] ). These changes are accompanied by losses of elasticity in most collagen-rich tissues, such as lungs, aorta and skin. Molecular changes include increased protein cross-linking and accumulation of yellow pigmented and fluorescent molecules, together with proteolytic fragments of native proteins.
Considerable evidence suggests that diabetes accelerates several of the age-related changes that affect long-lived proteins. Typically, diabetes is associated with an age-related increase in capillary membrane thickness, increased joint stiffness, and a decrease in arterial and lung elasticity [4] . Most interestingly, dietary restriction in rodents decreases the age-related rate of collagen changes, while also decreasing glycaemia [5, 6] .
Taken together, these observations led to the proposition and, over the years, the subsequent demonstration that tissue glycation and formation of the so-called Maillard/glycation end-products and cross-links might explain in part the changes affecting long-lived tissues [5] . As seen in Scheme 1, the Maillard reaction in vivo leads to the formation of a large number of protein adducts and cross-links, many of which have been found to accumulate in aging proteins. The Amadori product occupies a central role in the formation of a number of them. While some modifications such as pentosidine are present in relatively low amounts in old human skin and can originate from several precursors, the recently discovered glucosepane is a major lysine-arginine cross-link in the aging lens [7] . It is also present in old human skin, where it cross-links one out of three triple-helical strands of collagen, and is also increased 2-4-fold in collagen from diabetic rodents (D.R. Sell, K. Biemel, O. Riehl, M. Lederer, V.M. Monnier, T. Mustata and A. Vishwanathan, unpublished work).
In addition to modifications of collagen by Amadori compounds, formation of the latter has been suggested to play a role in diabetic nephropathy. Indeed, mice that were chronically treated with antibodies to glycated albumin had a lower progression rate of albuminuria and mesangial expansion [10] , suggesting a direct role of early (Amadori) glycation products in the pathogenesis of this disease.
The search for amadoriase enzymes in soil organisms
The data discussed above and the changes observed in the aging extracellular matrix suggested a strong link with the Maillard reaction in vivo, and that targeted reversal/ blocking of the Amadori product might be an useful strategy to prevent some of the glycation-dependent aging processes. With the eventual goal of developing a transgenic animal model expressing high levels of deglycating enzymes in order to specifically test the role of Amadori products in diabetes and aging, we initiated a search for the existence of deglycating activity in soil organisms, in the absence of confirmed evidence for the existence of deglycating activity in mammalian cells [11] [12] [13] .
Our initial approach using 1-deoxyfructosyl-ε-aminocaproic acid as sole carbon source led us to isolate a Pseudomonas sp. from soil that was able to deglycate a number of low-molecular-mass substrates [14] . The activity corresponded to a membrane-bound Cu 2+ enzyme of 106 kDa [15] .
Scheme 1 Chemical pathways of the Maillard reaction in vivo
The abbreviations are: AGE, advanced glycation end-product; CML, carboxymethyl-lysine; CEL, carboxyethyl-lysine; GALA, glyoxylic acid lysine amide; GOLA, glyoxal lysine amide; GODIC, glyoxal-derived imidazoline cross-link; MODIC, methylglyoxal-derived imidazoline cross-link; DOGDIC, 3-deoxyglucosone-derived imidazoline cross-link; DOLD, 3-deoxyglucosone lysine dimer; GOLD, glyoxal lysine dimer; MG, methylglyoxal; MOLD, methylglyoxal lysine dimer.
Scheme 2 Hydrolysis of 6-aminofructosylcaproic acid by two different pathways
Shown is the mechanism of enzymatic attack on to the Amadori product of ε-aminocaproic acid by amadoriase enzyme from Pseudomonas sp. ( Most surprisingly, however, the enzyme split the Amadori product at the N-alkylamine and not the ketoamine bond of the Amadori (Scheme 2), as previously reported by Horiuchi for fructosyl amino acid oxidase enzymes [16, 17] . Since neither our enzyme nor those of Horiuchi were able to deglycate proteins, we initiated a new search for amadoriase enzymes in soil organisms using a sterically inhibited substrate, 1-deoxyfructosyl adamantaneamine, in lieu of protein. This resulted in the isolation of an Aspergillus sp. which contained two amadoriase enzymes, amadoriase I and II [18, 19] .
Structural and functional properties of amadoriase enzymes from Aspergillus sp.
Amadoriase I and II are flavoenzymes with molecular masses of 51 and 49 kDa respectively. Both have been cloned [19, 20] . They oxidize low-molecular-mass glycated substrates into glucosone and H 2 O 2 , and, in that regard, are similar to most other amadoriase flavoenzymes that have been described to date (for references see [21] ). Most amadoriase enzymes of fungal origin share a very high percentage of structural similarity. Interestingly, amadoriase II expression in Aspergillus was inducible upon incubation with propylamine Amadori, suggesting presence of a promoter with Amadori responsive elements. Based on the 22% structural identity with sarcosine oxidase, its known crystal structure and the identification of FAD covalently linked to Cys 315 [22] , we hypothesized that Cys 342 in amadoriase I is the site of covalent attachment of FAD. This was demonstrated by site-directed mutagenesis and MALDI (matrix-assisted laser-desorption ionization) MS. The C342A and C342S mutants have a 10-fold increase in K m for fructosyl propylamine, and a 100-fold decrease in k cat /K m [20] . Furthermore, the endoproteinase Glu-C digest revealed the presence of two peptides containing the covalently bound FAD and FMN respectively, and the predicted peptides for the two mutants.
A major difference between amadoriases I and II was found in their Michaelis-Menten properties. Amadoriase I Table 1 show that the mutations resulted in a change in substrate specificity equivalent to a functional transformation of amadoriase II into amadoriase I.
In-depth kinetic and substrate studies were performed in order to understand the mechanism by which the enzyme oxidizes Amadori products [23] . The Amadori product at room temperature shows approx. 61% β-pyranose, 6% α-pyranose, 15% β-furanose, 16% α-furanose and about 2% keto forms [24] . D-Fructose, being 70% in the β-pyranose form, was found to be an inhibitor. The enzyme did not recognize the borohydride reduced form, 1-deoxyglucitolyl lysine, confirming the need for a cyclical configuration. Furanose analogues were not inhibitors.
Stopped-flow studies using fructosyl propylamine and O 2 as substrates showed that the reductive half-reaction is triphasic and generates intermediates that absorb at long wavelengths [23] . The data were consistent with either (1) the reaction of the substrate with the flavin followed by iminium deprotonation or hydrolysis and then product release, or (2) the formation of a flavin reduction intermediate, followed by product release (Scheme 3). The rate of product release after flavin reduction was lower than the anaerobic turnover rate, 14.4 s −1 , suggesting that it is not involved in the catalytic cycle and that reoxidation of the enzyme occurs in the E red − product complex, as indicated by the thick arrows in Scheme 3.
The problem of deglycating glycated proteins
Neither amadoriases I and II nor, to our knowledge, any of the published fructosyl amino acid oxidases have been found to be able to deglycate proteins, although several of them can deglycate protein digests [25] . This observation has severely limited the hope of efficiently utilizing amadoriase enzymes of the fructosylamine oxidase type in clinical assays, as well as in transgenic animal models of diabetes. While, however, most of the inhibition is likely to be related to steric effects, Kagan et al. [26] found that lysyl oxidase was inactive against native BSA but effectively oxidized albumin if its carboxyl functions were first amidated by chemical modification. Whereas lysyl oxidase is a Cu and not an FAD enzyme, this observation nevertheless suggested that electrostatic interactions might contribute to the inhibitory effect of glycated proteins as substrates of amadoriases I and II. In order to test this assumption, we glycated BSA (7 mg/ml) by incubation in 1 M glucose for 7 days, and amidated it with carbodi-imide-N-hydroxysuccinimide reagent in Hepes buffer at pH 8.0. At various time intervals the reaction was stopped by buffer exchange using gel filtration. As shown in Figure 1 there was an increase in enzymatic activity as a function of incubation time, i.e. the presumed degree of amidation of the negative charges. An apparent K m of 1.4 mg/ml was determined.
Conclusions
Biological aging results from the suboptimal ability of the organism to replace its damaged or altered molecules, thus leading to their progressive accumulation in cellular and extracellular compartments. This is in part the result of a lack of evolutionary pressure to evolve and retain efficient repair mechanisms needed for maintenance of life beyond the offspring rearing period. In that regard, the surprising discovery that fructosamine 3-phosphokinases in mammalian cells can deglycate proteins upon phosphorylation of the Amadori products [27, 28] strongly suggests that the intracellular formation of Amadori products is deleterious. Unfortunately, these kinases are ATP-dependent and thus of no use to prevent the consequences of the Amadori-dependent Maillard reaction in the extracellular compartment.
A potential solution to the problem of reversing the molecular lesions of the aging process may be found in micro-organisms, several of which have evolved powerful machineries for the degradation of amino acids modified by the Maillard reaction. Thus not only have deglycating enzymes been found in fungal and bacterial organisms, but also enzymes that can oxidize carboxymethyl-lysine into free lysine and glyoxalate [29] . Thus it is likely that many more enzymes will be found in micro-organisms that are of potential use for transgenic approaches against the aging process. However, the primary goal of the metabolic machinery in micro-organisms is to allow utilization of essential amino acids and nitrogen sources, explaining why their enzymes have not evolved naturally to attack modified proteins. Thus considerable protein engineering will be needed in order to adapt or create enzymes that can reverse the molecular lesions of aging.
